167 results
F-1
EX-10.12.1
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
evidence; or
7.1 (f) (iii)
it is independently developed by or for the Receiving Party by persons without access to the Confidential Information.
7.1 (f … information about third-party access to medication (benefits investigation and reimbursement requirements);
9.1 (c) (iii)
Coordination of refills;
9.1 (c
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 20
Current report (foreign)
8:45am
to provide the recipient with access to any additional information or to update any additional information or to correct any inaccuracies in any … BSA and Penetration X Dosing and Frequency X Market Access & Compliance Cuts X Price Incidence among live births 1:20,000 2 , multiplied by life
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Exhibit 99.4
Chiesi Farmaceutici S.p.A. Completes Acquisition of
Amryt Pharma Plc
Acquisition positions Chiesi to expand patient access … and acts as a force for good, for society and the planet. The goal of the Global Rare Diseases unit is to ensure equal access so as many people as possible
DRS/A
EX-10.12
AMYT
Amryt Pharma Plc
11 May 20
Draft registration statement (amended)
12:00am
evidence; or
7.1 (f) (iii)
it is independently developed by or for the Receiving Party by persons without access to the Confidential Information.
7.1 (f … information about third-party access to medication (benefits investigation and reimbursement requirements);
9.1 (c) (iii)
Coordination of refills;
9.1 (c
6-K
EX-99.3
ufiqxe7h4ox64 rs462q
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.4
nxke 699sg
4 Aug 22
Results of Annual General Meeting
7:38am
F-1
EX-10.12.5
78jbt0hvzuzmk0qkrdhs
23 Jun 20
Registration statement (foreign)
5:21pm
424B3
kf7nm58xv
31 Mar 22
Prospectus supplement
8:44am
6-K
EX-99.1
9r7qobua1qyns
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
x3bexlv81tbwb55ly vm
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.3
h1p as4pf
29 Oct 21
Current report (foreign)
6:05am
6-K
EX-99.2
7t7ku0u6p1sa
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
8z29md yedhuvxi
31 Jan 22
Prospectus supplement
7:35am
6-K
EX-99.2
q4ds93c5zm6
13 Sep 21
Current report (foreign)
8:48am
DRS/A
EX-10.12
cld7b2jjypo2c5nqm
11 May 20
Draft registration statement (amended)
12:00am
6-K
EX-99.1
08ekty lnfi
17 Dec 20
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
6:15am
6-K
EX-99.1
59vu6iv17 damcbi
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B3
r8cotz4ce8x 47ui4t
31 Jan 22
Prospectus supplement
7:33am